Moors & Cabot’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $722K | Sell |
1,566
-6
| -0.4% | -$3.04K | 0.03% | 447 |
|
|
2025
Q4 | $890K | Buy |
1,572
+37
| +2% | +$19.7K | 0.04% | 385 |
|
|
2025
Q3 | $686K | Buy |
1,535
+143
| +10% | +$68.6K | 0.03% | 443 |
|
|
2025
Q2 | $756K | Buy |
1,392
+225
| +19% | +$118K | 0.04% | 404 |
|
|
2025
Q1 | $578K | Sell |
1,167
-89
| -7% | -$49.2K | 0.03% | 444 |
|
|
2024
Q4 | $656K | Buy |
1,256
+97
| +8% | +$50.5K | 0.03% | 427 |
|
|
2024
Q3 | $569K | Hold |
1,159
| – | – | 0.03% | 463 |
|
|
2024
Q2 | $516K | Buy |
1,159
+26
| +2% | +$10.4K | 0.03% | 476 |
|
|
2024
Q1 | $452K | Hold |
1,133
| – | – | 0.02% | 534 |
|
|
2023
Q4 | $382K | Sell |
1,133
-135
| -11% | -$40.2K | 0.02% | 546 |
|
|
2023
Q3 | $371K | Buy |
1,268
+270
| +27% | +$84.3K | 0.03% | 526 |
|
|
2023
Q2 | $341K | Sell |
998
-436
| -30% | -$132K | 0.02% | 577 |
|
|
2023
Q1 | $366K | Sell |
1,434
-885
| -38% | -$218K | 0.03% | 541 |
|
|
2022
Q4 | $615K | Sell |
2,319
-162
| -7% | -$39.5K | 0.04% | 364 |
|
|
2022
Q3 | $465K | Buy |
2,481
+76
| +3% | +$16.3K | 0.04% | 419 |
|
|
2022
Q2 | $483K | Buy |
2,405
+130
| +6% | +$30.5K | 0.03% | 424 |
|
|
2022
Q1 | $686K | Buy |
2,275
+17
| +0.8% | +$4.97K | 0.04% | 381 |
|
|
2021
Q4 | $811K | Sell |
2,258
-37
| -2% | -$12.7K | 0.05% | 337 |
|
|
2021
Q3 | $763K | Buy |
2,295
+612
| +36% | +$206K | 0.05% | 336 |
|
|
2021
Q2 | $516K | Sell |
1,683
-30
| -2% | -$8.42K | 0.04% | 413 |
|
|
2021
Q1 | $419K | Buy |
1,713
+33
| +2% | +$8.3K | 0.03% | 426 |
|
|
2020
Q4 | $457K | Buy |
1,680
+33
| +2% | +$8.19K | 0.04% | 399 |
|
|
2020
Q3 | $390K | Sell |
1,647
-105
| -6% | -$23.6K | 0.04% | 393 |
|
|
2020
Q2 | $333K | Sell |
1,752
-18
| -1% | -$3.23K | 0.04% | 421 |
|
|
2020
Q1 | $292K | Hold |
1,770
| – | – | 0.04% | 380 |
|
|
2019
Q4 | $351K | Buy |
1,770
+90
| +5% | +$16.9K | 0.04% | 418 |
|
|
2019
Q3 | $301K | Buy |
1,680
+165
| +11% | +$28.5K | 0.03% | 443 |
|
|
2019
Q2 | $265K | Buy |
+1,515
| New | +$260K | 0.03% | 439 |
|
|
2018
Q4 | – | Sell |
-1,302
| Closed | -$250K | – | 540 |
|
|
2018
Q3 | $250K | Sell |
1,302
-78
| -6% | -$13.9K | 0.03% | 467 |
|
|
2018
Q2 | $220K | Sell |
1,380
-900
| -39% | -$137K | 0.03% | 501 |
|
|
2018
Q1 | $314K | Buy |
+2,280
| New | +$318K | 0.04% | 419 |
|
Other funds holding ISRG
VCM
VPM
Moors & Cabot's ISRG Position: Q1 2026 in Review
Moors & Cabot reduced its Intuitive Surgical (ISRG) stake by 0.38% in Q1 2026, selling an estimated $3.04K and leaving 1,566 shares worth $722K. The position accounts for 0.03% of the portfolio, ranked #447.
Moors & Cabot first reported a position in ISRG in Q1 2018 and has held it in 31 quarters since. The position peaked at $890K in Q4 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.
- Moors & Cabot held 1,566 shares of Intuitive Surgical worth $722K as of Q1 2026.
- Moors & Cabot sold 6 Intuitive Surgical shares in Q1 2026, an estimated $3.04K.
- Intuitive Surgical made up 0.03% of Moors & Cabot's portfolio in Q1 2026, its #447 holding.
- Moors & Cabot first reported a position in Intuitive Surgical in Q1 2018 and has held it in 31 quarters since.
- Moors & Cabot's Intuitive Surgical position peaked at $890K in Q4 2025.
- 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.
Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.